Watch Trial Troubles for Alzheimer Drugs - Bloomberg

Jul 23rd, 2015

Trial Troubles for Alzheimer Drugs

Eli Lilly's solanezumab may be the first Alzheimer's disease modifying agent on the market if Expedition-3 is successful. Bloomberg Intelligence's Asthika Goonewardene reports on "Market Makers." (Source: Bloomberg)

Top Video

Duration:1:39

Trump Says He Didn't Ask Xi For Any Favors on Iran

Duration:3:29

Trump-Xi Summit: What Was Discussed

Duration:9:48

Burns on Key Takeaways From the Trump-Xi Summit

Bloomberg Brief

Duration:0:30

Trump Says China Will Buy Over 200 Boeing Planes

Duration:4:00

Xi Hails ‘Landmark’ Summit as Trump Departs

Duration:0:43

Trump Says He Spoke to Xi About Guardrails for AI

Duration:2:53

Trump Says China Offered Help With Iran Negotiations

Duration:3:45

Comparing China and US Statements on Trump-Xi Summit

The China Show

Available on:

Listen onApple TV Listen onRoku Listen onSamsung TV Listen onFire TV Listen onAndroid TV Listen onRakuten TV Listen onHaystack News

Watch BTV in your area: